A recently published scientific study, “Joints for joints”, has, in somewhat cautious terms, stated that “cannabis could be an appropriate treatment for RA (rheumatoid arthritis).
In June 2018 DEA approved CBD in the form of Epidiolex, which is used for the treatment of seizures in children and adults. Thereby CBD got reclassified from Schedule 1 drug, which is an illegal substance, to a Schedule 5 “controlled substance”
Last year the Swedish medicinal company Enorama Pharma got permission from the Swedish Medical Products Agency to import and handle cannabis. They are now developing their medical cannabis chewing gum for the rapidly expanding global market.
Since cannabis still is illegal on the federal level in the US, many hospitals refuse to allow it. Instead they are treating terminally ill patients with opioids. The result is that these persons cannot communicate with their loved ones during their last hours alive.
The Multiple Sclerosis Society of Canada is investing $1.5 million in a new, never before researched study. They are teaming up with the Canadian Institutes of Health Research to perform this research. The goal is to see if MS could be treated with cannabis.
Gabriel Micallef is a pharmaceutical expert. Here he gives his view of what the future medical cannabis market in Europe could look like.
According to a General Social Survey from 2018 cannabis is gaining a record high support. 61% are backing legalization and seniors are getting more supportive by the day!
A new study, presented in the Journal of Policy Analysis and Management shows that the amount of working hours could be increased when it comes to older adults.
In 2016 the population in Florida overwhelmingly voted to allow medical cannabis. However, the governor at the time -Rick Scott (R)- signed a law that made smoking cannabis in any form or way illegal.
Cannabis Club Australia has started a petition for legalizing cannabis and letting Australian adults grow and consume cannabis legally . So far they have got 53 881 signatures..